{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:59:12Z","timestamp":1780520352229,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015286","name":"Hebei Provincial Key Research Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370176"],"award-info":[{"award-number":["82370176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470117"],"award-info":[{"award-number":["82470117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042025YXB011"],"award-info":[{"award-number":["2042025YXB011"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phymed.2025.157168","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:31:27Z","timestamp":1755127887000},"page":"157168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Compound Kushen Injection suppresses multiple myeloma progression via TOP1-targeted coordination of DNA damage and endoplasmic reticulum stress"],"prefix":"10.1016","volume":"147","author":[{"given":"Guopeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuerxunayi","family":"Rouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.157168_bib0001","doi-asserted-by":"crossref","first-page":"37343","DOI":"10.1074\/jbc.M313910200","article-title":"Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage","volume":"279","author":"Adachi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2025.157168_bib0002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1081\/CNV-120030218","article-title":"Development of the proteasome inhibitor Velcade (Bortezomib)","volume":"22","author":"Adams","year":"2004","journal-title":"Cancer Invest."},{"key":"10.1016\/j.phymed.2025.157168_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110940","article-title":"Interplay between symmetric arginine dimethylation and ubiquitylation regulates TDP1 proteostasis for the repair of topoisomerase I-DNA adducts","volume":"39","author":"Bhattacharjee","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2025.157168_bib0004","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41467-018-05058-y","article-title":"Genomic patterns of progression in smoldering multiple myeloma","volume":"9","author":"Bolli","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2025.157168_bib0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.adh7950","article-title":"DNA damage induces p53-independent apoptosis through ribosome stalling","volume":"384","author":"Boon","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.phymed.2025.157168_bib0006","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.leu.2404278","article-title":"Proteasome inhibitor bortezomib for the treatment of multiple myeloma","volume":"20","author":"Cavo","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.phymed.2025.157168_bib0007","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2020.03.006","article-title":"A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib","volume":"478","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157168_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2025.157168_bib0009","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1016\/j.apsb.2024.04.021","article-title":"Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis","volume":"14","author":"Cheng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2025.157168_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2025.157168_bib0011","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global Burden of Multiple Myeloma: a Systematic Analysis for the Global Burden of Disease Study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.phymed.2025.157168_bib0012","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing targeted protein degradation for cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2025.157168_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031649","article-title":"Multiple myeloma: challenges encountered and future options for better treatment","volume":"23","author":"Das","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157168_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914646","article-title":"Bortezomib is effective in the treatment of T lymphoblastic leukaemia by inducing DNA damage, WEE1 downregulation, and mitotic catastrophe","volume":"24","author":"Din","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157168_bib0015","doi-asserted-by":"crossref","first-page":"eadm8196","DOI":"10.1126\/sciadv.adm8196","article-title":"Human DNA topoisomerase I poisoning causes R loop-mediated genome instability attenuated by transcription factor IIS","volume":"10","author":"Duardo","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phymed.2025.157168_bib0016","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.tcb.2020.09.002","article-title":"When Endoplasmic Reticulum Proteostasis Meets the DNA Damage Response","volume":"30","author":"Gonz\u00e1lez-Quiroz","year":"2020","journal-title":"Trends. Cell Biol."},{"key":"10.1016\/j.phymed.2025.157168_bib0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/path.5097","article-title":"Integrating the DNA damage and protein stress responses during cancer development and treatment","volume":"246","author":"Gorgoulis","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.phymed.2025.157168_bib0018","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ncb2738","article-title":"ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death","volume":"15","author":"Han","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2025.157168_bib0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40164-022-00261-6","article-title":"Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma","volume":"11","author":"Haney","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.phymed.2025.157168_bib0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phymed.2025.157168_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154984","article-title":"Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway","volume":"118","author":"Huang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157168_bib0022","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13046-018-0948-3","article-title":"Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs\/ROS\/Trx1 signalling pathway","volume":"37","author":"Jin","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157168_bib0023","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1182\/blood.2020008734","article-title":"How I treat relapsed multiple myeloma","volume":"139","author":"Kastritis","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2025.157168_bib0024","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41418-022-00989-y","article-title":"Mutant p53: it's not all one and the same","volume":"29","author":"Kennedy","year":"2022","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.phymed.2025.157168_bib0025","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2025.157168_bib0026","doi-asserted-by":"crossref","first-page":"9946","DOI":"10.1073\/pnas.1334037100","article-title":"Proteasome inhibitors disrupt the unfolded protein response in myeloma cells","volume":"100","author":"Lee","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phymed.2025.157168_bib0027","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan5598","article-title":"ATM directs DNA damage responses and proteostasis via genetically separable pathways","volume":"11","author":"Lee","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.phymed.2025.157168_bib0028","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.molcel.2021.05.004","article-title":"Maintenance of organellar protein homeostasis by ER-associated degradation and related mechanisms","volume":"81","author":"Lemberg","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2025.157168_bib0029","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1039\/C6LC00078A","article-title":"Optofluidic restricted imaging, spectroscopy and counting of nanoparticles by evanescent wave using immiscible liquids","volume":"16","author":"Liang","year":"2016","journal-title":"Lab. Chip."},{"key":"10.1016\/j.phymed.2025.157168_bib0030","doi-asserted-by":"crossref","first-page":"28084","DOI":"10.1074\/jbc.M109.030601","article-title":"Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks","volume":"284","author":"Lin","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2025.157168_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109249","article-title":"Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response","volume":"118","author":"Lin","year":"2019","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.phymed.2025.157168_bib0032","first-page":"1145","article-title":"Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines","volume":"9","author":"Ling","year":"2003","journal-title":"Clinic. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157168_bib0033","article-title":"Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2025.157168_bib0034","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy","volume":"25","author":"Lohr","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2025.157168_bib0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature10760","article-title":"The DNA damage response and cancer therapy","volume":"481","author":"Lord","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2025.157168_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216218","article-title":"Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma","volume":"565","author":"Luo","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157168_bib0037","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1182\/blood-2011-06-363911","article-title":"Bortezomib-induced \"BRCAness\" sensitizes multiple myeloma cells to PARP inhibitors","volume":"118","author":"Neri","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2025.157168_bib0038","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1535-7163.MCT-04-0260","article-title":"The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim","volume":"4","author":"Nikrad","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phymed.2025.157168_bib0039","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","article-title":"The role of endoplasmic reticulum stress in human pathology","volume":"10","author":"Oakes","year":"2015","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.phymed.2025.157168_bib0040","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2025.157168_bib0041","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2013.48.7934","article-title":"International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation","volume":"32","author":"Palumbo","year":"2014","journal-title":"J. Clinic. Oncol."},{"key":"10.1016\/j.phymed.2025.157168_bib0042","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/sj.leu.2403109","article-title":"The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells","volume":"17","author":"Pei","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.phymed.2025.157168_bib0043","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/auto.6.1.10323","article-title":"Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells","volume":"6","author":"Periyasamy-Thandavan","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.phymed.2025.157168_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116348","article-title":"Design, synthesis and biological evaluation of matrine contains benzimidazole derivatives as dual TOPOI and PARP inhibitors for cancer therapy","volume":"270","author":"Qiu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2025.157168_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2025.157168_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123125","article-title":"Bortezomib in cancer therapy: mechanisms, side effects, and future proteasome inhibitors","volume":"358","author":"Sogbein","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2025.157168_bib0047","doi-asserted-by":"crossref","first-page":"eaba6290","DOI":"10.1126\/sciadv.aba6290","article-title":"A conserved SUMO pathway repairs topoisomerase DNA-protein cross-links by engaging ubiquitin-mediated proteasomal degradation","volume":"6","author":"Sun","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phymed.2025.157168_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114304","article-title":"Topoisomerase I inhibitors: challenges, progress and the road ahead","volume":"236","author":"Talukdar","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2025.157168_bib0049","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-19-1089","article-title":"Targeting topoisomerase I in the era of precision medicine","volume":"25","author":"Thomas","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157168_bib0050","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tig.2022.02.010","article-title":"The p53 network: cellular and systemic DNA damage responses in cancer and aging","volume":"38","author":"Vaddavalli","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.phymed.2025.157168_bib0051","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2025.157168_bib0052","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.blre.2018.11.003","article-title":"The impact of NF-\u03baB signaling on pathogenesis and current treatment strategies in multiple myeloma","volume":"34","author":"Vr\u00e1bel","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.phymed.2025.157168_bib0053","doi-asserted-by":"crossref","first-page":"192","DOI":"10.31083\/j.fbl2706192","article-title":"The role and mechanisms of action of natural compounds in the prevention and treatment of cancer and cancer metastasis","volume":"27","author":"Wang","year":"2022","journal-title":"Front. Biosci."},{"key":"10.1016\/j.phymed.2025.157168_bib0054","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/bph.15350","article-title":"Quercetin induces p53-independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species-dependent ferroptosis","volume":"178","author":"Wang","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157168_bib0055","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41375-020-0745-9","article-title":"A novel BCMA PBD-ADC with ATM\/ATR\/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma","volume":"34","author":"Xing","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.phymed.2025.157168_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.09.032","article-title":"IRE1\u03b1 silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer","volume":"187","author":"Xu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2025.157168_bib0057","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/biom5031652","article-title":"Inhibition of topoisomerase (DNA) I (TOP1): DNA damage repair and anticancer therapy","volume":"5","author":"Xu","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.phymed.2025.157168_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000317","article-title":"Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib","volume":"8","author":"Yang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phymed.2025.157168_bib0059","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/00498254.2023.2227976","article-title":"An integrated analytical strategy to decipher the metabolic profile of alkaloids in Compound Kushen injection based on UHPLC-ESI-QTOF\/MS(E)","volume":"53","author":"Zhang","year":"2023","journal-title":"Xenobiotica"},{"key":"10.1016\/j.phymed.2025.157168_bib0060","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/1389201022666210602105609","article-title":"Rapid screening of active components with topoisomerase I inhibitory activity in sophora alopecuroides L. based on ultrafiltration coupled with UPLC-QTOF-MS","volume":"23","author":"Zhang","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.phymed.2025.157168_bib0061","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2014.08.037","article-title":"Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways","volume":"355","author":"Zhao","year":"2014","journal-title":"Cancer Lett."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325008074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325008074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:34:17Z","timestamp":1773419657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325008074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":61,"alternative-id":["S0944711325008074"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157168","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compound Kushen Injection suppresses multiple myeloma progression via TOP1-targeted coordination of DNA damage and endoplasmic reticulum stress","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157168"}}